Cognitive-Behavioral Therapy + Meds Recommended Over Meds Alone for Insomnia
via HealthDayFRIDAY, May 1, 2026 -- Combination treatment of cognitive-behavioral therapy for insomnia (CBT-I) plus insomnia medication is recommended over insomnia medication alone for adults with chronic insomnia disorder, according to a clinical practice guideline issued by the American Academy of Sleep Medicine (AASM) and published online April 13 in the Journal of Clinical Sleep Medicine.
Daniel J. Buysse, M.D., from the School of Medicine at the University of Pittsburgh, and colleagues established clinical practice recommendations for combination treatment of chronic insomnia disorder in adults, defined as treatment with CBT-I started concurrently with pharmacotherapy. A task force of experts in sleep medicine was commissioned to develop recommendations.
The AASM suggests use of combination treatment with CBT-I plus insomnia medication over insomnia medication alone in adults with chronic insomnia disorder (conditional recommendation). There is a conditional recommendation against use of combination treatment of CBT-I plus insomnia medication over CBT-I alone for adults with chronic insomnia disorder.
"Our analysis suggests that CBT-I by itself is the most efficacious first-line treatment for insomnia. However, using medication with CBT-I may provide modest benefit for some specific outcomes, such as total sleep time," Buysse said in a statement. "These recommendations are meant to support thoughtful, patient‑centered decision‑making rather than a one‑size‑fits‑all approach."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-02 02:06
Read more
- Naloxone Has Limitations for Reversing ODs From Fentanyl, Sufentanil
- Lower Dietary Protein Intake Linked to Lower Dialysis Risk in CKD
- EPA Delays Decisions on 'Forever Chemicals'
- Adding Dilanubicel to Single-Unit Cord-Blood Transplantation Has Favorable Safety Profile
- New Plan Aims To Track Microplastics in U.S. Drinking Water, EPA Says
- Cumberland Pharmaceuticals Announces Expanded Indication for Caldolor (ibuprofen) Injection
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions